ERBB2 and neoplasm: All independent factors identified in the luminal ERBB2-negative cohort, apart from tumor size, were associated with high nodal burden in ILC also and were included in the lobular prediction model with an AUC of 0.74 (95% CI, 0.66-0.83) in the development set (Figure 1D).